Toxoplasmosis and Epilepsy — Systematic Review and Meta Analysis

PLoS Neglected Tropical Diseases

Volumn 9, Issue 2, 2015, Pages

  Ngoungou, Edgard B ^a,b   Bhalla, Devender ^a   Nzoghe, Amandine ^b   Dardé, Marie Laure ^a,c   Preux, Pierre Marie ^a,c  

^a UNIVERSITÉ DE LIMOGES   (France)

^b UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

^c LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; COCHRANE LIBRARY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; HUMAN; META ANALYSIS; NONHUMAN; RISK FACTOR; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS; CHRONIC DISEASE; COMPLICATION; MIDDLE AGED; ODDS RATIO; PARASITOLOGY; PATHOGENICITY; TOXOPLASMA;

CHRONIC DISEASE; EPILEPSY; HUMANS; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84924075066     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003525     Document Type: Article

References (43)

1. Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR, (2010) Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 51: 883–890. doi: 10.1111/j.1528-1167.2009.02481.x 20067507
2. Komolafe MA, Sunmonu TA, Afolabi OT, Komolafe EO, Fabusiwa FO, et al. (2012) The social and economic impacts of epilepsy on women in Nigeria. Epilepsy Behav 24: 97–101. doi: 10.1016/j.yebeh.2011.11.019 22445872
3. Ngugi AK, Bottomley C, Kleinschmidt I, Wagner RG, Kakooza-Mwesige A, et al. (2013) Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. Lancet Neurol 12: 253–263. doi: 10.1016/S1474-4422(13)70003-6 23375964
4. Burneo JG, Tellez-Zenteno J, Wiebe S, (2005) Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence. Epilepsy Res 66: 63–74. 16125900
5. Preux PM, Druet-Cabanac M, (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4: 21–31. 15620854
6. de Bittencourt PR, Adamolekum B, Bharucha N, Carpio A, Cossio OH, et al. (1996) Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia 37: 1121–1127. 8917065
7. Tenter AM, Heckeroth AR, Weiss LM, (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30: 1217–1258. 11113252
8. Pappas G, Roussos N, Falagas ME, (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39: 1385–1394. doi: 10.1016/j.ijpara.2009.04.003 19433092
9. Torgerson PR, Mastroiacovo P, (2013) The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 91: 501–508. doi: 10.2471/BLT.12.111732 23825877
10. Palmer BS, (2007) Meta-analysis of three case controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection. Seizure 16: 657–663. 17604653
11. Akyol A, Bicerol B, Ertug S, Ertabaklar H, Kiylioglu N, (2007) Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii. Seizure 16: 233–237. 17239629
12. Dalimi A, Abdoli A, (2012) Latent toxoplasmosis and human. Iran J Parasitol 7: 1–17. 23323085
13. Finsterer J, Auer H, (2013) Parasitoses of the human central nervous system. J Helminthol 87: 257–270. doi: 10.1017/S0022149X12000600 23046708
14. Critchley EM, Vakil SD, Hutchinson DN, Taylor P, (1982) Toxoplasma, Toxocara, and epilepsy. Epilepsia 23: 315–321. 7084141
15. Yazar S, Fehim A, Saban Y, Funda D, (2003) Investigation of probable relationship between toxoplasma gondii and cryptogenic epilepsy. Seizure 12: 107–109. 12566234
16. Zibaei M, Zamani Z, Esfahani AC, Anbari K, Nazer MR, (2011) Toxoplasma infection and epilepsy: A case-control study in Iran. Neurol Asia 16: 299–302.
17. Potasman I, Davidovitch M, Tal Y, Tal J, Zelnik N, et al. (1995) Congenital toxoplasmosis: a significant cause of neurological morbidity in Israel? Clin Infect Dis 20: 259–262. 7742426
18. Stommel EW, Seguin R, Thadani VM, Schwartzman JD, Gilbert K, et al. (2001) Cryptogenic epilepsy: an infectious etiology? Epilepsia 42: 436–438. 11442166
19. Veeranoot N, (2007) Toxoplasmosis: A silent threat in Southeast Asia. Res J Parasitol 2: 1–12.
20. Darde ML, (2008) Toxoplasma gondii, “new” genotypes and virulence. Parasite 15: 366–371. 18814708
21. Doskaya M, Caner A, Ajzenberg D, Degirmenci A, Darde ML, et al. (2013) Isolation of Toxoplasma gondii strains similar to Africa 1 genotype in Turkey. Parasitol Int 62: 471–474. doi: 10.1016/j.parint.2013.06.008 23811201
22. Stajner T, Vasiljevic Z, Vujic D, Markovic M, Ristic G, et al. (2013) Atypical strain of Toxoplasma gondii causing fatal reactivation after hematopoietic stem cell transplantion in a patient with an underlying immunological deficiency. J Clin Microbiol 51: 2686–2690. doi: 10.1128/JCM.01077-13 23761151
23. Pereira-Chioccola VL, Vidal JE, Su C, (2009) Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiol 4: 1363–1379. doi: 10.2217/fmb.09.89 19995194
24. Mercier A, Devillard S, Ngoubangoye B, Bonnabau H, Banuls AL, et al. (2010) Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon. PLoS Negl Trop Dis 4: e876. doi: 10.1371/journal.pntd.0000876 21072237
25. Gilbert RE, Stanford MR, Jackson H, Holliman RE, Sanders MD, (1995) Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ 310: 1037–1040. 7728057
26. Pfaff AW, de-la-Torre A, Rochet E, Brunet J, Sabou M, et al. (2014) New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis. Int J Parasitol 44: 99–107. doi: 10.1016/j.ijpara.2013.09.007 24200675
27. Kamuyu G, Bottomley C, Mageto J, Lowe B, Wilkins PP, et al. (2014) Exposure to multiple parasites is associated with the prevalence of active convulsive epilepsy in sub-saharan Africa. PLoS Negl Trop Dis 8: e2908. doi: 10.1371/journal.pntd.0002908 24875312
28. Quet F, Preux PM, Nicoletti A, (2008) Comment on “Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii”. Seizure 17: 296. 17977752
29. Hermes G, Ajioka JW, Kelly KA, Mui E, Roberts F, et al. (2008) Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation 5: 48. doi: 10.1186/1742-2094-5-48 18947414
30. Carruthers VB, Suzuki Y, (2007) Effects of Toxoplasma gondii infection on the brain. Schizophr Bull 33: 745–751. 17322557
31. Fischer HG, Nitzgen B, Reichmann G, Gross U, Hadding U, (1997) Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol Res 83: 637–641. 9272550
32. Halonen SK, Lyman WD, Chiu FC, (1996) Growth and development of Toxoplasma gondii in human neurons and astrocytes. J Neuropathol Exp Neurol 55: 1150–1156. 8939198
33. Ferguson DJ, Hutchison WM, (1987) The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice. Virchows Arch A Pathol Anat Histopathol 411: 39–43. 3107207
34. Vyas A, Kim SK, Giacomini N, Boothroyd JC, Sapolsky RM, (2007) Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci U S A 104: 6442–6447. 17404235
35. Ferguson DJ, Hutchison WM, (1987) An ultrastructural study of the early development and tissue cyst formation of Toxoplasma gondii in the brains of mice. Parasitol Res 73: 483–491. 3422976
36. Webster JP, (2001) Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes Infect 3: 1037–1045. 11580990
37. Stibbs HH, (1985) Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 79: 153–157. 2420295
38. Fuks JM, Arrighi RB, Weidner JM, Kumar Mendu S, Jin Z, et al. (2012) GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Pathog 8: e1003051. doi: 10.1371/journal.ppat.1003051 23236276
39. Haroon F, Handel U, Angenstein F, Goldschmidt J, Kreutzmann P, et al. (2012) Toxoplasma gondii actively inhibits neuronal function in chronically infected mice. PLoS One 7: e35516. doi: 10.1371/journal.pone.0035516 22530040
40. Kaushik M, Lamberton PH, Webster JP, (2012) The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. Horm Behav 62: 191–201. doi: 10.1016/j.yhbeh.2012.04.002 22521209
41. Webster JP, McConkey GA, (2010) Toxoplasma gondii-altered host behaviour: clues as to mechanism of action. Folia Parasitol (Praha) 57: 95–104. 20608471
42. Arrizabalaga G, Ruiz F, Moreno S, Boothroyd JC, (2004) Ionophore-resistant mutant of Toxoplasma gondii reveals involvement of a sodium/hydrogen exchanger in calcium regulation. J Cell Biol 165: 653–662. 15173192
43. Kim JY, Ahn HJ, Ryu KJ, Nam HW, (2008) Interaction between parasitophorous vacuolar membrane-associated GRA3 and calcium modulating ligand of host cell endoplasmic reticulum in the parasitism of Toxoplasma gondii. Korean J Parasitol 46: 209–216. doi: 10.3347/kjp.2008.46.4.209 19127325